KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

UVAMIN RETARD CAPSULES

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

 

GENERIC NAME:

NITROFURANTOIN

 

MANUFACTURER:

MEPHA LTD.

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

B

 

INDICATIONS:

Infection, urinary tract

 

SIDE EFFECTS:

Hypersensitivity reactions including anaphylaxis

angioedema

arthralgia

chills

drug fever

maculopapular, erythematous, or eczematous eruptions

myalgia

pruritus

urticaria

pneumonitis

Hematologic reactions, specifically granulocytopenia

leukopenia

megaloblastic anemia

thrombocytopenia

neurotoxicity

peripheral neuropathy

Aplastic anemia

benign intracranial hypertension

cyanosis

hemolytic anemia

hepatotoxicity, including hepatitis, cholestatic jaundice, chronic active hepatitis, and hepatic necrosis

optic neuritis

pancreatitis

pseudomembranous colitis

psychological disturbances, such as confusion

mental depression

psychotic reactions

severe skin reactions, including exfoliative dermatitis, erythema multiforme, and Stevens-Johnson syndrome

Gastrointestinal disturbances

headache

Rust-yellow to brown discoloration of urine

transient alopecia

Pseudomembranous colitis

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

Anemia

Debilitating disease

Diabetes mellitus

Electrolyte imbalance

Vitamin B deficiency

>> Glucose-6-phosphate dehydrogenase deficiency

Hypersensitivity to nitrofurans

>> Neuropathy, peripheral

>> Pulmonary disease

>> Renal function impairment

 

ADULT DOSE:

Antibacterial- Oral, 100 mg every twelve hours for seven days.

 

MAXIMUM ADULT DOSE:

 

PEDIATRIC DOSE:

Antibacterial- Children up to 12 years of age: Safety and efficacy have not been established. Children 12 years of age and older: See Usual adult dose . 

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

 

 

PREVIOUS

  

NEXT